Health costs of the UK-US trade deal on pharmaceuticals.
Where this comes from
- Record sourced from PubMed, PMID 42386321.
- Also identified by DOI 10.1136/bmj-2026-340588 and PMC identifier 13389864.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<b>Samuel Cross, Karl Claxton, and Andrew Hill</b> argue that diversion of billions of NHS funding to pay more for new drugs under the UK-US trade deal will harm public health and result in thousands of excess deaths